Adults with epilepsy: Is monotherapy the only answer?

Epilepsia

Volumn 38, Issue SUPPL. 2, 1997, Pages

  Berkovic, Samuel F ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Anticonvulsants; Drug interactions; Drug therapy; Tiagabine; Toxicity

Indexed keywords

EID: 7144220351     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb04531.x     Document Type: Article

References (20)

1. Ben-Menachem E. International experience with tiagabine add-on therapy. Epilepsia 1995;36(suppl 6):S14-21.
2. Leppik IE. Tiagabine: the safety landscape. Epilepsia 1995; 36(suppl 6):S10-3.
3. Shorvon SD, Chadwick D, Galbraith AW, Reynolds EH. One drug for epilepsy. BMJ 1977;1:474-6.
4. Wilder BJ. Treatment consideration in anticonvulsant monotherapy. Epilepsia 1987;28(suppl 6):S1-7.
5. Camfield PR, Camfield CS. Antiepileptic drug therapy: when is epilepsy truly intractable? Epilepsia 1996;37(suppl 1):S60-5.
6. Ferrendelli JA. Relating pharmacology to clinical practice: the pharmacological basis of rational polytherapy. Neurology 1995;45(suppl 2):S12-6.
7. Macdonald RL, Kelly KM. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 1994;35(suppl 4):S41-50.
8. Brodie MJ, Forrest G, Rapeport WG. Carbamazepine-10, 11-epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Br J Clin Pharmacol 1983;16:747-50.
9. Pisani F, Di Perri I, Perucca E, Richens A. Interaction of lamotrigine with sodium valproate. Lancet 1993;341:1224.
10. Obeso JA, Artieda J, Rothwell JC, Day B, Thompson P, Marsden CD. The treatment of severe action myoclonus. Brain 1989;112:765-77.
11. Schapel GJ, Black AB, Lam EL, Robinson M, Dollman WB. Combination vigabatrin and lamotrigine therapy for intractable epilepsy. Seizure 1996;5:51-6.
12. Pledger GW, Kramer LD. Clinical trials of investigational antiepileptic drugs. Epilepsia 1991;32:716-21.
13. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
14. Leber PD. Hazards of inference: the active control investigation. Epilepsia 1989;30(suppl 1):S57-63.
15. Faught E, Sachedo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active controlled trial. Neurology 1993;43:688-92.
16. Bourgeois B, Leppik IE, Sackellares JC, et al. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993;43:693-6.
17. Schachter SC. Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 1995;36(suppl 6):S2-6.
18. Alarcon G, Binnie CD, Elwes RDC, Polkey CE. Monotherapy antiepileptic drug trials in patients undergoing presurgical assessment: methodological problems and possibilities. Seizure 1995;4:293-301.
19. Cahill WT, Sachdeo RC, Schachter S, et al. Dose-ranging study to determine the safety and tolerability of tiagabine HCl administered as monotherapy. Epilepsia 1993;34(suppl 6):36.
20. Schachter S, Biton V, Boellner S, et al. Safety and efficacy of tiagabine HCl monotherapy in the treatment of partial seizures: high versus low dose. Epilepsia 1995;36(suppl 3):S148.